Results 21 to 30 of about 55,024 (294)
Immune Thrombocytopenic Purpura in a Patient with Covid-19
Immune Thrombocytopenic Purpura and Covid-19 Immune thrombocytopenia with lower-extremity purpura, mucosal bleeding, and cerebral microhemorrhage developed during the clinical course in a 65-year-o...
A. Zulfiqar+3 more
semanticscholar +1 more source
The standard of care for immune thrombotic thrombocytopenic purpura today
Targeted therapy of immune thrombotic thrombocytopenic purpura (iTTP) requires acurate and prompt diagnosis and differentiation from complement‐mediated hemolytic uremic syndrome and other causes of thrombotic microangiopathy.
X. Zheng
semanticscholar +1 more source
Severe immune thrombocytopenic purpura in critical COVID-19
COVID-19 is a new disease with many undescribed clinical manifestations. We report herein a case of severe immune thrombocytopenic purpura (ITP) in a critical COVID-19 patient. A patient presented a severe episode of immune thrombocytopenia (
V. Lévesque+4 more
semanticscholar +1 more source
A Retrospective Observational Single-Centre Study on the Burden of Immune Thrombocytopenia (ITP) [PDF]
Background: German data on economic consequences of immune thrombocytopenia (ITP) are limited. Patients and Methods: A retrospective, observational study based on chart review of adult patients with a confirmed diagnosis of ITP was conducted at a German ...
Ackermann, Birgit+6 more
core +1 more source
Diagnosis and management of immune thrombocytopenic purpura (ITP) remain largely dependent on clinical expertise and observations more than on evidence derived from clinical trials of high scientific quality.
F. Rodeghiero+19 more
semanticscholar +1 more source
Immune Thrombocytopenic Purpura (ITP) is an autoimmune thrombocytopenia with a shortened platelet survival and relative bone marrow failure. The pathogenesis involves antibody production, cytokine release, T-cell impairment, complement activation, and ...
R. Castelli+4 more
semanticscholar +1 more source
Graves’ disease-induced immune thrombocytopenic purpura in an African female: a case report
Background Immune thrombocytopenic purpura is a condition associated with an unusual, unexplained, and sometimes very severe reduction in the level of platelets in the blood.
Kwabena Oteng Agyapong+7 more
doaj +1 more source
Objective: Determination of significance of immature platelet fraction (IPF%) in diagnosed patients of Immune thrombocytopenic purpura (ITP). Study Design: It was a cross-sectional study.
Mohammad Shabih Haider+5 more
doaj +1 more source
Pathogenicity of anti-ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura. [PDF]
BACKGROUND: Acquired thrombotic thrombocytopenic purpura (TTP) is an autoimmune disease in which anti-ADAMTS13 autoantibodies cause severe enzyme deficiency.
Crawley, JT+3 more
core +2 more sources
The purpose of this study was to evaluate neutropenia following intravenous immunoglobulin (IVIG) therapy in adults with immune thrombocytopenic purpura (ITP). Our analysis included 88 patients with ITP, who received IVIG from January 2006 to March 2016,
Sang-Bo Oh, H. Shin
semanticscholar +1 more source